OLIG1 Inhibitors
The chemical class of OLIG1 Inhibitors represents a diverse group of compounds that exert their effects by modulating various cellular signaling pathways and processes. These chemicals do not directly inhibit OLIG1 but can affect its function and expression in an indirect manner. Compounds like Retinoic Acid, Lithium Chloride, and Cyclopamine, which influence neural differentiation and development pathways. Retinoic Acid affects gene expression patterns in neural cells, potentially modifying OLIG1's role in oligodendrocyte differentiation. Lithium Chloride and Cyclopamine, by modulating Wnt and Hedgehog signaling pathways respectively, can also have an impact on OLIG1 expression during neural development.
Compounds that inhibit specific signaling molecules and pathways. PD98059, SB203580, LY294002, and Rapamycin target key molecular pathways such as MAPK/ERK, p38 MAPK, PI3K, and mTOR, respectively. These pathways are crucial in various aspects of cell growth, differentiation, and stress response, all of which are important for OLIG1's function in oligodendrocyte development and maintenance. Additionally, compounds like Fluorocitrate, Bisindolylmaleimide I, Kenpaullone, Curcumin, and Sulforaphane act on various other pathways that can indirectly influence OLIG1, highlighting the complex network of signaling pathways that regulate neural cell function and development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Modulates Wnt signaling, which can affect OLIG1 expression during neural development. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits the MAPK/ERK pathway, potentially impacting OLIG1-related signaling in oligodendrocyte development. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially affecting OLIG1's role in stress responses in neural cells. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which can influence OLIG1 activity and oligodendrocyte differentiation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR signaling, potentially affecting OLIG1 function in cell growth and differentiation. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Inhibits the Hedgehog signaling pathway, potentially impacting OLIG1 expression in neural development. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibits Protein Kinase C, potentially affecting signaling pathways related to OLIG1. | ||||||
Kenpaullone | 142273-20-9 | sc-200643 sc-200643A sc-200643B sc-200643C | 1 mg 5 mg 10 mg 25 mg | $61.00 $153.00 $231.00 $505.00 | 1 | |
Inhibits GSK-3β, a kinase involved in Wnt signaling, potentially impacting OLIG1 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates various signaling pathways including NF-κB, potentially influencing OLIG1 activity. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Acts on Nrf2 pathway, potentially influencing OLIG1 activity in oxidative stress response. | ||||||